carbamazepine has been researched along with Central Nervous System Cysticercosis in 13 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the response to albendazole treatment in patients who had SSECTL and new onset seizures treated with antiepileptic drugs (AED) in a prospective clinical trial." | 9.13 | Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. ( Chattopadhyay, A; Khandelwal, N; Sawhney, IM; Thussu, A, 2008) |
| " The pharmacokinetic parameters were analyzed by analysis of variance followed by the Tukey-Kramer test." | 6.70 | Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. ( Dreossi, SA; Garcia, FS; Lanchote, VL; Takayanagui, OM, 2002) |
| "Carbamazepine levels were measured at 6 months." | 5.39 | Effect of carbamazepine therapy on homocysteine, vitamin B12 and folic acid levels in children with epilepsy. ( Aggarwal, A; Chillar, N; Faridi, MM; Kumar, V; Mittal, H; Sharma, S, 2013) |
| "To evaluate the response to albendazole treatment in patients who had SSECTL and new onset seizures treated with antiepileptic drugs (AED) in a prospective clinical trial." | 5.13 | Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. ( Chattopadhyay, A; Khandelwal, N; Sawhney, IM; Thussu, A, 2008) |
| "Epilepsy is one of the most common neurological disorders worldwide." | 2.82 | Characteristics of people with epilepsy in three Eastern African countries - a pooled analysis. ( Amos, A; Escheu, G; Harrison, W; Hauke, P; Kaducu, J; Keller, L; Matuja, W; Ngowi, BJ; Ovuga, E; Pfausler, B; Richter, V; Schmidt, V; Schmutzhard, E; Stelzle, D; Welte, TM; Winkler, AS, 2022) |
| " The pharmacokinetic parameters were analyzed by analysis of variance followed by the Tukey-Kramer test." | 2.70 | Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. ( Dreossi, SA; Garcia, FS; Lanchote, VL; Takayanagui, OM, 2002) |
| "Epilepsy is the commonest clinical presentation, though it may also present with headache, symptoms of raised intracranial tension, hydrocephalus and ocular symptoms depending upon the localisation of the parasitic cysts." | 2.52 | Antiepileptic drugs for seizure control in people with neurocysticercosis. ( Mathew, A; Sharma, M; Singh, T, 2015) |
| "Carbamazepine levels were measured at 6 months." | 1.39 | Effect of carbamazepine therapy on homocysteine, vitamin B12 and folic acid levels in children with epilepsy. ( Aggarwal, A; Chillar, N; Faridi, MM; Kumar, V; Mittal, H; Sharma, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Stelzle, D | 1 |
| Kaducu, J | 1 |
| Schmidt, V | 1 |
| Welte, TM | 1 |
| Ngowi, BJ | 1 |
| Matuja, W | 1 |
| Escheu, G | 1 |
| Hauke, P | 1 |
| Richter, V | 1 |
| Ovuga, E | 1 |
| Pfausler, B | 1 |
| Schmutzhard, E | 1 |
| Amos, A | 1 |
| Harrison, W | 1 |
| Keller, L | 1 |
| Winkler, AS | 1 |
| Santhosh, AP | 1 |
| Kumar Goyal, M | 1 |
| Modi, M | 1 |
| Kharbanda, PS | 1 |
| Ahuja, CK | 1 |
| Tandyala, N | 1 |
| Prabhat, N | 1 |
| Singh, R | 1 |
| Mehta, S | 1 |
| Vinay Mahesh, K | 1 |
| Panda, PK | 1 |
| Sharawat, IK | 1 |
| Ramos-Zúñiga, R | 1 |
| Pérez-Gómez, HR | 1 |
| Gaytán-Martínez, LA | 1 |
| Vega-Ruiz, B | 1 |
| Soto-Rodríguez, S | 1 |
| Rochín-Mozqueda, A | 1 |
| Sharma, M | 1 |
| Singh, T | 1 |
| Mathew, A | 1 |
| Asnis, D | 1 |
| Kazakov, J | 1 |
| Toronjadze, T | 1 |
| Bern, C | 1 |
| Garcia, HH | 1 |
| McAuliffe, I | 1 |
| Bishop, H | 1 |
| Lee, L | 1 |
| Grossmann, R | 1 |
| Garcia, MA | 1 |
| Di John, D | 1 |
| Sharma, P | 1 |
| Garg, RK | 1 |
| Verma, R | 1 |
| Singh, MK | 1 |
| Shukla, R | 1 |
| Kumar, V | 1 |
| Aggarwal, A | 1 |
| Sharma, S | 1 |
| Chillar, N | 1 |
| Mittal, H | 1 |
| Faridi, MM | 1 |
| Sharma, K | 1 |
| Wahi, J | 1 |
| Phadke, RV | 1 |
| Varma, A | 1 |
| Jain, VK | 1 |
| Thussu, A | 1 |
| Chattopadhyay, A | 1 |
| Sawhney, IM | 1 |
| Khandelwal, N | 1 |
| Bhatia, R | 1 |
| Desai, S | 1 |
| Garg, A | 1 |
| Padma, MV | 1 |
| Prasad, K | 1 |
| Tripathi, M | 1 |
| Singhi, P | 1 |
| Ray, M | 1 |
| Lanchote, VL | 1 |
| Garcia, FS | 1 |
| Dreossi, SA | 1 |
| Takayanagui, OM | 1 |
2 reviews available for carbamazepine and Central Nervous System Cysticercosis
| Article | Year |
|---|---|
Characteristics of people with epilepsy in three Eastern African countries - a pooled analysis.
Topics: Adult; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Epilepsy; Female; Humans; Male; Neur | 2022 |
Antiepileptic drugs for seizure control in people with neurocysticercosis.
Topics: Adolescent; Adult; Anticonvulsants; Brain Diseases; Carbamazepine; Child; Child, Preschool; Epilepsy | 2015 |
3 trials available for carbamazepine and Central Nervous System Cysticercosis
| Article | Year |
|---|---|
Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Humans; Levetiracetam; M | 2021 |
Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Carbamazepine; Cerebral Cortex; Child; Child, Prescho | 2008 |
Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Anticonvulsants; Area Under Curve; Carbamazepine; Chromatography, | 2002 |
8 other studies available for carbamazepine and Central Nervous System Cysticercosis
| Article | Year |
|---|---|
Carbamazepine or levetiracetam: Which one is better in neurocysticercosis?
Topics: Anticonvulsants; Carbamazepine; Humans; Levetiracetam; Neurocysticercosis | 2022 |
[Temporal lobe epilepsy and active neurocysticercosis: two representative case reports].
Topics: Albendazole; Anomia; Anthelmintics; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Citalopram | 2015 |
Neurocysticercosis in the infant of a pregnant mother with a tapeworm.
Topics: Albendazole; Animals; Anthelmintics; Anti-Inflammatory Agents; Anticonvulsants; Carbamazepine; Dexam | 2009 |
Risk of seizure recurrence in patients of new-onset partial seizure having a solitary cysticercus granuloma of brain or normal neuroimaging.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cohort Studies; Electroe | 2011 |
Effect of carbamazepine therapy on homocysteine, vitamin B12 and folic acid levels in children with epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Folic Acid; Homocysteine; | 2013 |
Migraine-like visual hallucinations in occipital lesions of cysticercosis.
Topics: Adolescent; Adult; Albendazole; Anticonvulsants; Antiprotozoal Agents; Carbamazepine; Drug Therapy, | 2002 |
Isolated facial myokymia as a presenting feature of pontine neurocysticercosis.
Topics: Anti-Inflammatory Agents; Anticonvulsants; Carbamazepine; Diagnosis, Differential; Facial Nerve Dise | 2008 |
Focal seizures with single small ring-enhancing lesion.
Topics: Acute Disease; Albendazole; Anthelmintics; Anticonvulsants; Brain Edema; Carbamazepine; Diagnosis, D | 1999 |